Molecular Imaging News and Research RSS Feed - Molecular Imaging News and Research

Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems

Cubresa's new NuPET scanner enables simultaneous PET/MRI in existing third-party MRI systems

A compact PET scanner called NuPET has been commercially released for simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing third-party MRI systems. [More]
Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

To me the most exciting aspect of pre-clinical imaging is its broad range, from very basic science up to applied science. You deal with a range of disciplines including biology, chemistry, physics, biochemistry, biophysics, cell biology and of course medicine, as the aim is the translation of research to humans. [More]
Transforming MR images into body composition measurements: an interview with Olof Leinhard

Transforming MR images into body composition measurements: an interview with Olof Leinhard

Today's medical science utilizes relatively simple anthropometric measures that describe the body, such as body mass index (BMI) and waist circumference. All of these measures are approximations of the body with the intention to characterize what's inside reflecting underlying phenomena that underpin the risk for different diseases. [More]
Scientists discover Hobit, Blimp1 genes that fight disease-causing pathogens

Scientists discover Hobit, Blimp1 genes that fight disease-causing pathogens

Melbourne researchers have uncovered the genes responsible for the way the body fights infection at the point of 'invasion' - whether it's the skin, liver, lungs or the gut. [More]
Researchers examine neuropsychological effect in ecstasy users

Researchers examine neuropsychological effect in ecstasy users

Researchers from the University of Liverpool have conducted a study examining the effect ecstasy has on different parts of the brain. [More]
Structure of fibril protein could lead to specific targets for diagnosis, treatment of Parkinson's disease

Structure of fibril protein could lead to specific targets for diagnosis, treatment of Parkinson's disease

Chemists have identified the complex chemical structure of the protein that stacks together to form fibrils in the brains of Parkinson's disease patients. Armed with this knowledge, researchers can identify specific targets for diagnosis and treatment. [More]
Doctors now have better tool to assess individual kidney function

Doctors now have better tool to assess individual kidney function

Doctors now have a much-improved tool to assess individual kidney function, thanks to the work of an international team led by University of Saskatchewan medical imaging specialists Drs. Carl and Michal Wesolowski. [More]
Distinct brain networks support retrieval of old and recent memories

Distinct brain networks support retrieval of old and recent memories

When we remember events which occurred recently, the hippocampus is activated. This area in the temporal lobe of the brain is a hub for learning and memory. But what happens, if we try to remember things that took place years or decades ago? Neuroscientists at the Ruhr-University Bochum and the Osaka University have been able to give some answers to this question. [More]
Oral pill could improve breast cancer diagnostic techniques

Oral pill could improve breast cancer diagnostic techniques

The ongoing debate about breast cancer diagnostics has left many women confused — particularly over what age they should get mammograms and who needs treatment. An issue with current methods is that they often identify lumps but cannot conclusively pinpoint which ones are cancerous. To help resolve this uncertainty, researchers have developed a pill that could improve imaging techniques so that only cancerous tumors light up. [More]
Renishaw inVia to support development of nanomolecular probes in Kircher Laboratory at Memorial Sloan Kettering

Renishaw inVia to support development of nanomolecular probes in Kircher Laboratory at Memorial Sloan Kettering

The Kircher laboratory at Memorial Sloan Kettering is developing novel nanoprobes for molecular imaging, image-guided therapy and theranostics. [More]
Advances in the field of MPI: an interview with Professor Kannan Krishnan

Advances in the field of MPI: an interview with Professor Kannan Krishnan

In around 2004, there was a Phillips paper that discussed a new imaging technique called MPI. At that time, I had an eager, promising graduate student named Matt Ferguson who wanted a project, so I asked him to take a look. [More]
MR Solutions introduces new 3D in vivo confocal microscope for preclinical research

MR Solutions introduces new 3D in vivo confocal microscope for preclinical research

MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs. [More]
Intracellular process of autophagy plays role in prostate cancer development, shows research

Intracellular process of autophagy plays role in prostate cancer development, shows research

Research from investigators at Rutgers Cancer Institute of New Jersey and the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, shows the intracellular process of autophagy plays a role in the development of prostate cancer. [More]
Molecular imaging and radiochemistry: the importance of instrumentation. An interview with Professor Björn Wängler

Molecular imaging and radiochemistry: the importance of instrumentation. An interview with Professor Björn Wängler

I’m Björn Wängler, Professor for Molecular Imaging and Radiochemistry at the medical faculty Mannheim of Heidelberg University. I’m a radiopharmaceutical chemist by background and completed my PhD in 2004 at the University of Mainz. [More]
A more effective method for detecting metastatic prostate cancer

A more effective method for detecting metastatic prostate cancer

Conventional imaging methods have limited sensitivity for detecting metastatic prostate cancer. With appropriate, timely treatment vital to survival and quality of life, better imaging has been an ongoing goal. [More]
New imaging test detects prostate cancer much better than any other tests in use today

New imaging test detects prostate cancer much better than any other tests in use today

Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today. [More]
Siemens Healthcare introduces new, cost-effective Biograph Horizon PET/CT system

Siemens Healthcare introduces new, cost-effective Biograph Horizon PET/CT system

Siemens Healthcare has launched the new versatile and cost-effective Biograph Horizon PET/CT system, which offers premium performance at an attractive total cost of ownership. [More]
Experimental drugs that modify cell metabolism also halt tumor growth

Experimental drugs that modify cell metabolism also halt tumor growth

Experimental drugs that alter cell metabolism also halted tumor growth and extended survival in mice with cancers linked to changes in the same gene, according to a new study led by researchers at NYU Langone Medical Center, its Laura and Isaac Perlmutter Cancer Center and Massachusetts General Hospital. [More]
PET-MRI combination may change management of high-risk cancer patients

PET-MRI combination may change management of high-risk cancer patients

PET/CT and whole-body MRI detect extraskeletal disease that may change the management of high-risk breast and prostate cancer patients, according to a recent study reported in the December issue of The Journal of Nuclear Medicine. [More]
Zecotek Photonics receives order for patented LFS scintillation crystals

Zecotek Photonics receives order for patented LFS scintillation crystals

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that it has received an order for its patented Lutetium Fine Silicate (LFS) scintillation crystals from a specialized medical imaging device manufacturer based in the United States. [More]
Advertisement
Advertisement